OTIS GREEN: Open Payments
NPI 1629561451 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,206 in 131 payments from 27 companies in 2025. Trend: 2023 $553 · 2024 $1,379 · 2025 $3,206
Food & beverage: $3,206
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $496 |
| GlaxoSmithKline, LLC. | 15 | $323 |
| Verona Pharma, Inc. | 12 | $281 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $234 |
| Regeneron Healthcare Solutions, Inc. | 7 | $223 |
| Viatris Specialty LLC | 9 | $204 |
| Insmed, Inc. | 8 | $159 |
| Merck Sharp & Dohme LLC | 5 | $147 |
| Mallinckrodt Hospital Products Inc. | 6 | $143 |
| United Therapeutics Corporation | 4 | $107 |
Products named: DUPIXENT, Ohtuvayre, AIRSUPRA, YUPELRI, NUCALA, FASENRA, TEZSPIRE, ACTHAR.
Industry payments across FL — which companies pay providers there.
